Skip to main content

Advertisement

Log in

An unusual cause of diarrhea in a child with nephrotic syndrome: Answers

  • Clinical Quiz
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

All data have been presented in the manuscript.

Code availability

Not applicable.

References

  1. Angarone M, Snydman DR (2019) Diagnosis and management of diarrhea in solid-organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13550

    Article  PubMed  Google Scholar 

  2. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, Sato S (2011) IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol 178:735–743

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16:219–230

    Article  CAS  PubMed  Google Scholar 

  4. Cavalcanti E, Armentano R, Lolli I (2020) Crohn’s disease following rituximab treatment for follicular lymphoma in a patient with synchronous gastric signet ring cells carcinoma: a case report and literature review. Cancer Res Treat 52:1291–1295

    PubMed  PubMed Central  Google Scholar 

  5. Ardelean DS, Gonska T, Wires S, Cutz E, Griffiths A, Harvey E, Tse SM, Benseler SM (2010) Severe ulcerative colitis after rituximab therapy. Pediatrics 126:e243-246

    Article  PubMed  Google Scholar 

  6. Tsuzuki Y, Shiomi R, Ashitani K, Miyaguchi K, Osaki A, Ohgo H, Kim R, Sasaki A, Yamada T, Miyakawa Y, Nakamoto H, Imaeda H (2021) Rituximab-induced ileocolitis in a patient with gastric MALToma: a case report and literature review. Intern Med 60:731–738

    Article  PubMed  PubMed Central  Google Scholar 

  7. Iijima K, Sako M, Nozu K (2017) Rituximab for nephrotic syndrome in children. Clin Exp Nephrol 21:193–202

    Article  CAS  PubMed  Google Scholar 

  8. Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, Wetzels J, Alhasan K, Banerjee S, Bhimma R, Bonilla-Felix M, Cano F, Christian M, Hahn D, Kang HG, Nakanishi K, Safouh H, Trachtman H, Xu H, Cook W, Vivarelli M, Haffner D (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38:877–919

    Article  PubMed  Google Scholar 

  9. Topaloğlu R, Gülhan B, Çelegen K, İnözü M, Hayran M, Düzova A, Ozaltin F (2019) Rituximab for children with difficult-to-treat nephrotic syndrome: its effects on disease progression and growth. Front Pediatr 7:313

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sinha A, Bhatia D, Gulati A, Rawat M, Dinda AK, Hari P, Bagga A (2015) Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome. Nephrol Dial Transplant 30:96–106

    Article  CAS  PubMed  Google Scholar 

  11. Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384:1273–1281

    Article  CAS  PubMed  Google Scholar 

  12. Kallash M, Smoyer WE, Mahan JD (2019) Rituximab use in the management of childhood nephrotic syndrome. Front Pediatr 7:178

    Article  PubMed  PubMed Central  Google Scholar 

  13. McAtee CL, Lubega J, Underbrink K, Curry K, Msaouel P, Barrow M, Muscal E, Lotze T, Srivaths P, Forbes LR, Allen C, Bernhardt MB (2021) Association of rituximab use with adverse events in children, adolescents, and young adults. JAMA Netw Open 4:e2036321

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bonanni A, Calatroni M, D’Alessandro M, Signa S, Bertelli E, Cioni M, Di Marco E, Biassoni R, Caridi G, Ingrasciotta G, Bertelli R, Di Donato A, Bruschi M, Canepa A, Piaggio G, Ravani P, Ghiggeri GM (2018) Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome. Br J Clin Pharmacol 84:1238–1249

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Grenda R, Jarmużek W, Rubik J, Migdał M, Pronicki M (2015) Fatal rituximab-associated lung injury syndrome in a patient treated with rituximab for recurrence of post-transplant nephrotic syndrome. Pediatr Transplant 19:E115-120

    Article  PubMed  Google Scholar 

  16. Galassi G, Testa F, Bianchi F, Cappelli G, Chiari A (2017) Acute demyelinating neuropathy associated with rituximab treatment in a patient with relapsing nephrotic syndrome. CEN Case Rep 6:215–216

    Article  PubMed  PubMed Central  Google Scholar 

  17. Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113:4834–4840

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Eckmann JD, Chedid V, Quinn KP, Bonthu N, Nehra V, Raffals LE (2020) De novo colitis associated with rituximab in 21 patients at a tertiary center. Clin Gastroenterol Hepatol 18:252–253

    Article  PubMed  Google Scholar 

  19. Morita K, Shibano T, Maekawa K, Hattori M, Hida N, Nakamura S, Takeshima Y (2019) Crohn’s disease following rituximab treatment in a patient with refractory nephrotic syndrome. CEN Case Rep 8:55–60

    Article  PubMed  Google Scholar 

  20. Machida S, Kobayashi S, Yodoshi T (2022) Rituximab-induced Crohn’s disease in a child with refractory nephrotic syndrome. Pediatr Int 64:e15285

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Düzova.

Ethics declarations

Ethics approval

Not applicable.

Consent for publication

An informed consent was obtained from the parents.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This refers to the article that can be found at https://doi.org/10.1007/s00467-023-06020-x.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baltu, D., Kurt Sukur, E.D., Gumus, E. et al. An unusual cause of diarrhea in a child with nephrotic syndrome: Answers. Pediatr Nephrol 38, 3977–3981 (2023). https://doi.org/10.1007/s00467-023-06021-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-023-06021-w

Keywords

Navigation